Prescription drug · ANDA
perphenazine NDC 51407-695
Perphenazine 4 mg/1 · Tablet · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-695-01 | 51407069501 | 100 TABLET in 1 BOTTLE (51407-695-01)Marketed from Dec 21, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- perphenazine
- Generic name (nonproprietary)
- perphenazine
- Active ingredients
- Perphenazine — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205232
- Marketing start
- Listing expires
- Other FDA classes
- Phenothiazines (Chemical structure)
- Identifiers
- Product ID 51407-695_29f7902b-4fd6-8122-e063-6294a90a13a0SPL ID 29f7902b-4fd6-8122-e063-6294a90a13a0SPL set ID f0ea4d18-643d-7acb-e053-2a95a90a9ea7RxCUI 198075, 198076, 198077, 198078UNII FTA7XXY4EZ
- Pharmacologic class
- Phenothiazine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407069501followed by a unit qualifier and the quantityPackage 51407-0695-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Perphenazine tablets, USP are indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine tablets, USP have not been shown effective for the management of behavioral complications in patients with mental retardation.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205232
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1043 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1041 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1042 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1044 |
| perphenazine | Perphenazine 4 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-592 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-591 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-694 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-593 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-594 |
| perphenazine | Perphenazine 16 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-697 |
| perphenazine | Perphenazine 8 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-696 |
| perphenazine | Perphenazine 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3257 |